Annual CFF
-$9000.00
-$9000.00-100.00%
31 December 2023
Summary:
XBiotech annual cash flow from financing activities is currently -$9000.00, with the most recent change of -$9000.00 (-100.00%) on 31 December 2023. During the last 3 years, it has risen by +$409.71 million (+100.00%). XBIT annual CFF is now -100.01% below its all-time high of $77.47 million, reached on 31 December 2015.XBIT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$64.00 K
+$16.00 K+33.33%
30 September 2024
Summary:
XBiotech quarterly cash flow from financing activities is currently $64.00 thousand, with the most recent change of +$16.00 thousand (+33.33%) on 30 September 2024. Over the past year, it has increased by +$59.00 thousand (+1180.00%). XBIT quarterly CFF is now -99.92% below its all-time high of $75.33 million, reached on 30 June 2015.XBIT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$10.17 M
+$59.00 K+0.58%
30 September 2024
Summary:
XBiotech TTM cash flow from financing activities is currently $10.17 million, with the most recent change of +$59.00 thousand (+0.58%) on 30 September 2024. Over the past year, it has increased by +$10.18 million (+113066.67%). XBIT TTM CFF is now -92.12% below its all-time high of $129.03 million, reached on 30 June 2015.XBIT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | +1180.0% | +10000.0% |
| 3 y3 years | +100.0% | +100.1% | +115.1% |
| 5 y5 years | -104.5% | -77.8% | -73.9% |
XBIT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | +100.0% | -99.4% | +100.1% | at high | +114.1% | |
| 5 y | 5 years | -100.0% | +100.0% | -99.4% | +100.0% | -75.8% | +102.5% |
| alltime | all time | -100.0% | +100.0% | -99.9% | +100.0% | -92.1% | +102.5% |
XBiotech Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $64.00 K(+33.3%) | $10.17 M(+0.6%) |
| June 2024 | - | $48.00 K(-99.5%) | $10.11 M(+0.6%) |
| Mar 2024 | - | $10.05 M(>+9900.0%) | $10.05 M(<-9900.0%) |
| Dec 2023 | -$9000.00(<-9900.0%) | $0.00(-100.0%) | -$9000.00(0.0%) |
| Sept 2023 | - | $5000.00(-135.7%) | -$9000.00(-35.7%) |
| June 2023 | - | -$14.00 K(<-9900.0%) | -$14.00 K(<-9900.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2022 | - | $0.00(0.0%) | $33.00 K(-100.0%) |
| June 2022 | - | $0.00(-100.0%) | -$72.01 M(+7.5%) |
| Dec 2021 | -$67.01 M(-83.6%) | $33.00 K(-100.0%) | -$67.01 M(-0.3%) |
| Sept 2021 | - | -$72.04 M(-1911.8%) | -$67.19 M(-1049.3%) |
| June 2021 | - | $3.98 M(+289.0%) | $7.08 M(+109.4%) |
| Mar 2021 | - | $1.02 M(-781.3%) | $3.38 M(-100.8%) |
| Dec 2020 | -$409.72 M(-1073.3%) | -$150.00 K(-106.7%) | -$409.72 M(+0.8%) |
| Sept 2020 | - | $2.23 M(+702.2%) | -$406.40 M(-0.5%) |
| June 2020 | - | $278.00 K(-100.1%) | -$408.34 M(+10.1%) |
| Mar 2020 | - | -$412.08 M(<-9900.0%) | -$370.73 M(-980.7%) |
| Dec 2019 | $42.10 M(>+9900.0%) | $3.17 M(+1001.4%) | $42.10 M(+8.1%) |
| Sept 2019 | - | $288.00 K(-99.2%) | $38.92 M(+0.7%) |
| June 2019 | - | $37.90 M(+5014.0%) | $38.64 M(+5114.0%) |
| Mar 2019 | - | $741.00 K(>+9900.0%) | $741.00 K(+268.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $201.00 K(-99.4%) | $0.00(0.0%) | $201.00 K(-2.0%) |
| Sept 2018 | - | $0.00(0.0%) | $205.00 K(-18.0%) |
| June 2018 | - | $0.00(-100.0%) | $250.00 K(-69.2%) |
| Mar 2018 | - | $201.00 K(+4925.0%) | $811.00 K(-97.6%) |
| Dec 2017 | $33.32 M(+1031.9%) | $4000.00(-91.1%) | $33.32 M(-5.9%) |
| Sept 2017 | - | $45.00 K(-92.0%) | $35.40 M(-0.3%) |
| June 2017 | - | $561.00 K(-98.3%) | $35.51 M(-0.4%) |
| Mar 2017 | - | $32.71 M(+1474.3%) | $35.66 M(+1111.2%) |
| Dec 2016 | $2.94 M(-96.2%) | $2.08 M(+1206.9%) | $2.94 M(+239.2%) |
| Sept 2016 | - | $159.00 K(-77.5%) | $868.00 K(+17.5%) |
| June 2016 | - | $707.00 K(>+9900.0%) | $739.00 K(-99.0%) |
| Mar 2016 | - | $0.00(-100.0%) | $75.36 M(-2.7%) |
| Dec 2015 | $77.47 M(+22.6%) | $2000.00(-93.3%) | $77.47 M(-37.2%) |
| Sept 2015 | - | $30.00 K(-100.0%) | $123.32 M(-4.4%) |
| June 2015 | - | $75.33 M(+3475.3%) | $129.03 M(+140.3%) |
| Mar 2015 | - | $2.11 M(-95.4%) | $53.70 M(-15.0%) |
| Dec 2014 | $63.20 M(+424.7%) | $45.85 M(+697.9%) | $63.20 M(+264.2%) |
| Sept 2014 | - | $5.75 M(>+9900.0%) | $17.35 M(+49.5%) |
| June 2014 | - | $0.00(-100.0%) | $11.61 M(0.0%) |
| Mar 2014 | - | $11.61 M | $11.61 M |
| Dec 2013 | $12.04 M(+65.4%) | - | - |
| Dec 2012 | $7.28 M | - | - |
FAQ
- What is XBiotech annual cash flow from financing activities?
- What is the all time high annual CFF for XBiotech?
- What is XBiotech annual CFF year-on-year change?
- What is XBiotech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for XBiotech?
- What is XBiotech quarterly CFF year-on-year change?
- What is XBiotech TTM cash flow from financing activities?
- What is the all time high TTM CFF for XBiotech?
- What is XBiotech TTM CFF year-on-year change?
What is XBiotech annual cash flow from financing activities?
The current annual CFF of XBIT is -$9000.00
What is the all time high annual CFF for XBiotech?
XBiotech all-time high annual cash flow from financing activities is $77.47 M
What is XBiotech annual CFF year-on-year change?
Over the past year, XBIT annual cash flow from financing activities has changed by -$9000.00 (-100.00%)
What is XBiotech quarterly cash flow from financing activities?
The current quarterly CFF of XBIT is $64.00 K
What is the all time high quarterly CFF for XBiotech?
XBiotech all-time high quarterly cash flow from financing activities is $75.33 M
What is XBiotech quarterly CFF year-on-year change?
Over the past year, XBIT quarterly cash flow from financing activities has changed by +$59.00 K (+1180.00%)
What is XBiotech TTM cash flow from financing activities?
The current TTM CFF of XBIT is $10.17 M
What is the all time high TTM CFF for XBiotech?
XBiotech all-time high TTM cash flow from financing activities is $129.03 M
What is XBiotech TTM CFF year-on-year change?
Over the past year, XBIT TTM cash flow from financing activities has changed by +$10.18 M (+113066.67%)